# Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung Cancer

> **NCT00079287** · PHASE3 · COMPLETED · sponsor: **Japan Multinational Trial Organization**

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** carboplatin
- **DRUG:** docetaxel
- **DRUG:** gemcitabine hydrochloride
- **DRUG:** paclitaxel
- **DRUG:** vinorelbine tartrate

## Key facts

- **NCT ID:** NCT00079287
- **Lead sponsor:** Japan Multinational Trial Organization
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-03
- **Primary completion:** —
- **Final completion:** 2008-11
- **Target enrollment:** — (—)
- **Last updated:** 2013-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00079287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00079287, "Vinorelbine, Gemcitabine, and Docetaxel Compared With Paclitaxel and Carboplatin in Treating Patients With Advanced Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00079287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*